<br />
HEMATOLOGY<br />
EMJ Hematol. 2017 Suppl 9 • europeanmedical-journal.com<br />
INSIDE<br />
The Pivotal Role of Proteasome<br />
Inhibition in Myeloma Treatment<br />
THE PIVOTAL ROLE OF PROTEASOME<br />
INHIBITION IN MYELOMA TREATMENT<br />
This symposium took place on 26th March 2017, as a part of the<br />
European Group for Blood and Marrow Transplantation (EBMT)<br />
Annual Meeting in Marseille, France<br />
Chairperson<br />
Meletios Dimopoulos1<br />
Speakers<br />
Nikhil C. Munshi,2 Pieter Sonneveld3<br />
1. Department of Clinical Therapeutics, National and Kapodistrian University of Athens,<br />
School of Medicine, Athens, Greece<br />
2. Harvard Medical School; Dana-Farber Cancer Institute, Boston, Massachusetts, USA<br />
3. Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands<br />
Disclosure: Prof Dimopoulos has received honoraria and consultin<a title="EMJ Hematol. 2017 Suppl 9 page 1" href="http://viewer.zmags.com/publication/691a4326?page=1"> HEMATOLOGY EMJ Hematol. 2017 Suppl 9 • europeanme</a>
<a title="EMJ Hematol. 2017 Suppl 9 page 2" href="http://viewer.zmags.com/publication/691a4326?page=2"> THE PIVOTAL ROLE OF PROTEASOME INHIBITION IN MYEL</a>
<a title="EMJ Hematol. 2017 Suppl 9 page 3" href="http://viewer.zmags.com/publication/691a4326?page=3"> smouldering MM (SMM), and eventually MM. The term</a>
<a title="EMJ Hematol. 2017 Suppl 9 page 4" href="http://viewer.zmags.com/publication/691a4326?page=4"> eligible tend to be younger and fitter, and thus g</a>
<a title="EMJ Hematol. 2017 Suppl 9 page 5" href="http://viewer.zmags.com/publication/691a4326?page=5"> ICAM-1 </a>
<a title="EMJ Hematol. 2017 Suppl 9 page 6" href="http://viewer.zmags.com/publication/691a4326?page=6"> PFS1 </a>
<a title="EMJ Hematol. 2017 Suppl 9 page 7" href="http://viewer.zmags.com/publication/691a4326?page=7"> and most high-risk patients are startin</a>
<a title="EMJ Hematol. 2017 Suppl 9 page 8" href="http://viewer.zmags.com/publication/691a4326?page=8"> 1.0~6-month increase in median PFS Proba</a>
<a title="EMJ Hematol. 2017 Suppl 9 page 9" href="http://viewer.zmags.com/publication/691a4326?page=9"> ASCT, and Rd) but did not have refractory disease</a>
<a title="EMJ Hematol. 2017 Suppl 9 page 10" href="http://viewer.zmags.com/publication/691a4326?page=10"> 2015;16(16):1617-29. 16. Paiva B et al. New crite</a>